GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pluri PLUR · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.18

-4.84%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$1.0m

FY2017FY2026

Net income

−$23.8m

FY2017FY2026

Free cash flow

−$20.2m

FY2017FY2026

Shareholders' equity

−$23.0m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$1.0m$1.3m$326,000$287,000$234,000—$23,000$54,000$50,000—
Research and development$15.3m$12.9m$12.4m$15.7m$24.4m$30.1m$20.1m$24.6m$22.6m$21.1m
Operating income−$24.9m−$22.2m−$22.2m−$27.2m−$41.6m−$50.6m−$29.5m−$35.5m−$33.7m−$28.0m
Net income−$23.8m−$22.6m−$20.9m−$28.3m−$41.2m−$49.9m−$29.2m−$35.3m−$26.1m−$27.8m
Diluted earnings per share-2.20-2.44-3.76-5.46-9.94-12.41-9.09-17.73-18.06-21.17

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$24.9m$38.7m$39.5m$50.8m$68.1m$93.5m$65.5m$31.3m$39.0m$37.5m
Cash and short-term investments$7.8m$20.6m$30.0m$40.2m$55.0m$65.0m$46.3m$23.7m$29.9m$26.1m
Total liabilities$42.3m$39.5m$34.1m$35.5m$35.9m$36.4m$9.4m$9.5m$10.5m$7.3m
Debt$34.9m$34.0m$29.6m$29.9m$28.8m$24.6m$1.6m———
Shareholders' equity−$23.0m−$6.8m$96,000$13.4m$30.0m$57.2m$56.1m$21.8m$28.5m$30.3m
Shares outstanding11m9m6m5m4m4m3m2m1m1m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−$19.6m−$18.2m−$18.0m−$22.9m−$36.5m−$30.9m−$26.4m−$29.5m−$21.4m−$21.6m
Capital spending−$633,000−$1.6m−$323,000−$262,000−$280,000−$373,000−$270,000−$239,000−$342,000−$378,000
Free cash flow−$20.2m−$19.8m−$18.3m−$23.1m−$36.8m−$31.3m−$26.6m−$29.7m−$21.7m−$22.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$335,000$167,000$198,000$316,000$398,000$427,000$185,000$326,000
Operating income−$5.5m−$6.6m−$6.6m−$6.3m−$6.6m−$5.4m−$5.0m−$5.2m
Net income−$5.9m−$6.2m−$6.5m−$5.8m−$7.6m−$6.1m−$3.0m−$5.9m
Diluted earnings per share-0.54-0.57-0.71-0.63-0.82-0.66-0.53-1.06
Cash from operations−$4.0m−$4.0m−$5.0m−$5.0m−$5.0m−$4.0m−$4.0m−$4.0m
Total assets$24.9m$26.1m$30.6m$33.7m$38.7m$37.4m$30.9m$35.4m
Cash and short-term investments$7.8m$9.5m$12.7m$15.5m$20.6m$26.3m$21.3m$26.0m
Debt$28.4m$28.0m$28.5m$28.2m$27.9m$25.5m$24.4m$25.9m
Shareholders' equity−$23.0m−$18.6m−$14.6m−$11.4m−$6.8m−$4.5m−$8.0m−$5.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue52.4%—-9.8%
Operating income-2.9%-13.2%0.7%
Net income-5.6%-13.7%0.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-2003.1%-3255.2%——
Net margin-1973.0%-3224.7%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-0.6-1.2-1.1-0.8-0.8-0.9-6.2-1.1-2.1-3.2
Price to sales13.120.772.983.9134.8—————

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-18%-13%-38%-51%-68%155%-50%-40%-14%37%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 8-to-1 reverse split · 1 Apr 2024
  • 10-to-1 reverse split · 25 Jul 2019
  • 200-to-1 reverse split · 26 Nov 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.